Cell Therapy News Volume 6.13 | Mar 16 2005

Human Embryonic Stem Cells Grown Animal-free
Article

Heart Stems Cells Located in Mice
Article

Two Chemical Compounds Boost Immune Cells’ Ability to Suppress HIV Without Gene Therapy, UCLA AIDS Institute Study Finds
Article

‘Smart’ Immune Cells Kill More Cancer
Article

MIF Knockout Mice Protected From Type 1 Diabetes
Article

Cancer Cells Put into Deep Sleep
Scientists have found a way to block the development of cancer by putting tumour cells into a permanent coma.
Article

Silence the Gene, Save the Cell: RNA Interference as Promising Therapy for ALS
Article 1

Cytokine IL-17E Enhances Virulizin’s Antitumor Activity
Article

Craze for Stem Cell Therapy Spreads in Russia Despite Danger Warnings
Article

Anti Cancer Virotherapy Well Tolerated in First Human Administration
Article

First Korean Stem Cell-Based “Dream Drug” Enters Commercial Testing
Article

ABSTRACT, REVIEWS, & SPECIAL REPORTS

Cryopreservation of Human Embryonic Stem Cells without the Use of a Programmable Freezer
Abstract

Differentiation of Adult Human Bone Marrow Mesenchymal Stem Cells into Schwann-like Cells In Vitro
Abstract

Immunotherapy with Autologous Antigen Presenting Cells for the Treatment of Androgen Independent Prostate Cancer
Abstract

Mesenchymal Stem Cells (MSC) as Therapeutic Cytoreagents for Gene Therapy
Abstract

Parkin Gene Therapy for alpha-Synucleinopathy: A Rat Model of Parkinson’s Disease
Abstract

UK Leads Race to Produce World’s First Clinical Grade Stem Cells
The University of Sheffield has received a 2.6m grant to create some of the world’s first embryonic stem cell lines that can be used for medicinal purposes.
Article

Massachusetts Poll Backs Research on Stem Cells, But Opposes Cloning
Article

Bay Area Council and Bay Area Economic Forum Jointly Announce Their Endorsement for Stem Cell Headquarters
Letter to Site Search Committee Explores Strength of Region
Article

UCLA Launches $20M Stem Cell Institute to Investigate HIV, Cancer and Neurological Disorders
Article

BUSINESS NEWS

Agilent Technologies Introduces LC Column for Separation of Complex Protein Samples; Product Enhances Protein Detection and Identification for Biomarker Research
Article

Chromos to Acquire Anosys
Article

Coratus Genetics Picks PPD for Gene Therapy Trial
Article

Gamida Cell Names Dr. Yael Margolin as the Company’s New President and CEO; StemEx Receives FDA Orphan Drug Designation
Article

Biopharmaceutical Pioneer GammaCan Announces Commencement of Phase II Clinical Trial
Article

Greer Executive Vice President to Present at 61st Annual American Academy of Allergy Asthma & Immunology Meeting
Article

ImmunoGen Gets $2 Million Milestone Fee From Sanofi-Aventis Group
Article

Nanogen Issued Patent for Ligation-Based Strand Displacement Amplification Technologies for DNA Analysis
Article

Seattle Genetics Achieves Milestone under Antibody-Drug Conjugate Agreement with Genentech
Article

MARKET REPORTS

Malachite Management has joined forces with established and reputable authors and publishers to bring you the following market reports outlining the very latest in Cell Therapy, Gene Therapy, and Immunotherapeutic approaches to Cancer. 

“Cell Therapy – Technologies, Markets, and Companies” is over 400 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the cell therapy industry worldwide.
For more information, including order forms, please see:

Cell Therapy Report Summary
Cell Therapy Sample Chapter
Cell Therapy Table of Contents Vol. 1  Vol. 2
Cell Therapy Order Form

“Gene Therapy – Technologies, Markets, and Companies” is over 500 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the gene therapy industry worldwide.
For more information, including order forms, please see:

Gene Therapy Report Summary
Gene Therapy Table of Contents Vol. 1 Vol. 2
Gene Therapy Order Form

The Immunotherapy Reports cover the most recent developments in the immunotherapeutic approaches to cancer.

A Shift in Cancer Immunotherapy Strategies?
Immunotherapy Strategies Executive Summary
Immunotherapy Strategies Table of Contents

Future Perspectives in Cancer Immunotherapy
Future Perspectives Executive Summary
Future Perspectives Table of Contents

Immunotherapy Reports Order Form

NATIONAL INSTITUTES OF HEALTH

Notice of Limited Competition Request for Competing Applications: NHLBI Minority Undergraduate Biomedical Education Program
Link

Genomics of Transplantation Cooperative Research Program(RFA-AI-05-022)
Link

NINDS Institutional Center Core Grants to Support Neuroscience Research (PAR-05-070)
Link

Career Development Award to Promote Diversity in Neuroscience Research (PAR-05-071)
Link

All new CBER information can be reached from the What’s New page

SOPP 8508 – Procedures for Handling Adverse Reaction Reports Related to “361” Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
Link

Medical Devices; Hematology and Pathology Devices; Reclassification from Class III to Class II of Automated Blood Cell Separator Device Operating by Centrifugal Separation Principle; Proposed Rule
Link

ICH Guidance for Industry: M2: eCTD Specification; Questions & Answers and Change Requests
Link

Substantially Equivalent 510(k) Device – COBE Spectra Apheresis System & Trima Automated Blood Component Collection System – (Gambro BCT, Inc)
Link

Substantially Equivalent 510(k) Device – ALYX Component Collection System – (Baxter Healthcare Corp)
Link

Vaccines and Related Biological Products Advisory Committee Roster – Update
Link

Blood Products Advisory Committee Roster – Update
Link

For Country-Specific & International Regulatory Resources, Including Regulatory Agencies Such As the FDA, EMEA, & More Please Visit The Regulatory Page

NEWS & UPDATES

UNITED STATES

FDA
Hubbard to Retire From FDA; Lutter to Serve as Replacement
Link

Vaccines and Related Biological Products Advisory Committee; Notice of Meeting
Link

NEW ZEALAND

Medsafe
GMP Certified Contract Testing Laboratories
Link

JOB POSTINGS IN CELL THERAPY NEWS ARE FREE!
For information on posting an opportunity email: info@connexoncreative.com

Acting President
San Diego, California (California Institute of Regenerative Medicine)

Cellular Production Lead Technician
Seattle, WA (Fred Hutchinson Cancer Research Center)

Director of Biostatistics & Epidemiology 
Rockville, MD (Center for Biologics Evaluation and Research)

Director of Cell Therapy
New York, NY (New York Blood Center)

Director of Research Programs 
Toronto, Ontario (Ontario Genomics Institute)

Faculty Positions in Stem Cell Research 
Ottawa, Ontario (Ottawa Health Research Institute)

Pharmacologist (enter Requisition Code 0412768)
Exton, Pennsylvania (Therakos, Inc.)

Post Doctoral Fellow (enter Requisition Code 0408577)
Somerville, New Jersey (Ethicon)

Post Doctoral or Engineer Positions 
Toronto, Ontario (Centre for Computational Biology Hospital for Sick Children)

Principal/Senior Scientist (enter Requisition Code 0408581)
Somerville, New Jersey (Ethicon)

Product Manager (Immunology)
Vancouver, BC (StemCell Technologies)

Project Manager (Research & Development) 
Vancouver, BC (StemCell Technologies)

Senior Scientist 
Brussels, Belgium (Beta-Cell NV)

Scientist (enter Requisition Code 0408593)
Somerville, New Jersey (Ethicon)

Stem Cell Specialist
Philadelphia, PA (Children’s Hospital of Philadelphia)

Quality Control Technologist
 Vancouver, BC (StemCell Technologies)

International Society for Cellular Therapy
www.celltherapy.org

Upcoming Meetings & Conferences:

2005 Cell Therapy Audioconference Series

May 3-4, 2005 Current Good Tissue Practice. Vancouver, BC
Workshop Chairs: Janice Davis-Sproul, MAS, MT (ASCP) SBB (John Hopkins University) & John McMannis, PhD (MD Anderson Cancer Center)
Email

May 4-7th, 2005 11th Annual ISCT Meeting. Vancouver, BC
Program Themes Include: Tissue Engineering, Mesenchymal Stem Cells, Immunotherapy, & Hematopoietic Stem Cells
Email

May 4-7th, 2005 Applications of Flow Cytometry in Marrow and Stem Cell Transplantation. Vancouver, BC
Email

ISCT ACQUIRES NEW JOURNAL TO MERGE WITH CYTOTHERAPY
Cytotherapy now incorporates Cytokines, Cellular and Molecular Therapy Journal
 

Join ISCT ($130) and receive the journal as a benefit of membership
http://www.celltherapy.org/mem_app.htm

Current Volume:Volume 7, Number 1 / March 2005

Cytotherapy publishes original research, reviews, meeting reports, special focus issues and letters in the general field of cell therapy. The scope of the journal includes basic and applied research with hematopoietic and non-hematopoietic stem cells , immune cells, and antigen-presenting cells. Therapeutic topics within the scope of Cytotherapy include ex-vivo and in-vivo aspects of gene therapy, immunotherapy, stem cell transplantation and tissue regeneration. Cytotherapy particularly welcomes
contributions from researchers, clinicians, technicians and individuals involved in regulatory aspects of cell therapy.
www.cytotherapy.com